
Alaunos Therapeutics
Formerly ZIOPHARM Oncology, developing novel therapeutics for the treatment of cancer.
Market cap
$18.4m
Enterprise value
$18m
Share price
$2.10 ZIOP
Authorizing premium user...
Formerly ZIOPHARM Oncology, developing novel therapeutics for the treatment of cancer.